For the quarter ending 2025-09-27, K had -$114M decrease in cash & cash equivalents over the period. $359M in free cash flow.
| Cash Flow | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 |
|---|---|---|---|---|
| Net income | 314 | 303 | 308 | 368 |
| Depreciation and amortization | 94 | 91 | 92 | 94 |
| Impairment of property | 0 | 0 | 0 | 0 |
| Postretirement benefit plan expense (benefit) | -5 | -6 | -6 | 21 |
| Deferred income taxes | 14 | 19 | 68 | 37 |
| Stock compensation | - | - | - | 89 |
| Loss on russia divestiture | - | - | - | 0 |
| Stock compensation | 15 | 35 | -44 | - |
| Other | 26 | -6 | 23 | 83 |
| Postretirement benefit plan distributions | 0 | 0 | 0 | 0 |
| Postretirement benefit plan contributions | 12 | 133 | 12 | 0 |
| Trade receivables | 27 | 90 | -16 | -87 |
| Inventories | -57 | -4 | 46 | -18 |
| Accounts payable | -70 | 26 | -106 | -106 |
| All other current assets and liabilities | -169 | 65 | 197 | -8 |
| Net cash provided by (used in) operating activities | 503 | 169 | 116 | 467 |
| Additions to properties | 144 | 148 | 176 | 188 |
| Issuance of notes receivable | - | - | - | 0 |
| Repayments from notes receivable | - | - | - | 0 |
| Purchase of marketable securities | 0 | 2 | 72 | 49 |
| Sales of marketable securities | 14 | 14 | 84 | 64 |
| Settlement of net investment hedges | 21 | 34 | 0 | 0 |
| Purchases of available for sale securities | - | - | - | 0 |
| Sales of available for sale securities | - | - | - | 0 |
| Other | 5 | 0 | -12 | -12 |
| Net cash provided by (used in) investing activities | -156 | -170 | -152 | -161 |
| Net increase (reduction) of notes payable, with maturities less than or equal to 90 days | - | - | - | -27 |
| Issuances of notes payable, with maturities greater than 90 days | - | - | - | 27 |
| Reductions of notes payable, with maturities greater than 90 days | - | - | - | 0 |
| Net issuances (reductions) of notes payable | -424 | 407 | 550 | - |
| Issuances of long-term debt | 0 | 0 | - | 0 |
| Reductions of long-term debt | 0 | 1 | 631 | 1 |
| Net issuances of common stock | 14 | 46 | 42 | 23 |
| Common stock repurchases | - | - | - | 0 |
| Cash dividends | 203 | 198 | 197 | 196 |
| Proceeds received from debt issued and retained by wk kellogg co | - | - | - | 0 |
| Cash retained by wk kellogg co at separation | - | - | - | 0 |
| Other | -13 | -14 | -1 | -4 |
| Net cash provided by (used in) financing activities | -455 | 32 | -313 | -190 |
| Effect of exchange rate changes on cash and cash equivalents | -6 | -7 | -15 | 9 |
| Increase (decrease) in cash and cash equivalents | -114 | 24 | -364 | 125 |
| Cash and cash equivalents at beginning of period | 354 | 330 | 694 | 569 |
| Cash and cash equivalents at end of period | 240 | 354 | 330 | 694 |
KELLANOVA (K)
KELLANOVA (K)